| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/CMDC.202000056 |
| P698 | PubMed publication ID | 32181986 |
| P50 | author | Gerhard Klebe | Q87855685 |
| Andreas Heine | Q89174405 | ||
| P2093 | author name string | Martin Stieler | |
| Christian Büchold | |||
| Ralf Pasternack | |||
| Martin Hils | |||
| Marisa Schmitt | |||
| P2860 | cites work | Autoimmune antibody in a hemorrhagic patient interacts with thrombin-activated factor XIII in a unique manner | Q77911881 |
| A highly sensitive fluorometric assay for determination of human coagulation factor XIII in plasma | Q80507835 | ||
| Three-dimensional structure of a transglutaminase: human blood coagulation factor XIII | Q24564521 | ||
| PHENIX: a comprehensive Python-based system for macromolecular structure solution | Q24654617 | ||
| Processing of X-ray diffraction data collected in oscillation mode | Q26778468 | ||
| Structure of active coagulation factor XIII triggered by calcium binding: basis for the design of next-generation anticoagulants | Q27687108 | ||
| XDS | Q27860472 | ||
| Features and development of Coot | Q27861079 | ||
| Transglutaminase 5 cross-links loricrin, involucrin, and small proline-rich proteins in vitro | Q28205261 | ||
| Identification of tissue transglutaminase as the autoantigen of celiac disease | Q28243044 | ||
| Tissue transglutaminase has intrinsic kinase activity: identification of transglutaminase 2 as an insulin-like growth factor-binding protein-3 kinase | Q28255156 | ||
| Factor XIII: novel structural and functional aspects | Q30156007 | ||
| Screening for the preferred substrate sequence of transglutaminase using a phage-displayed peptide library: identification of peptide substrates for TGASE 2 and Factor XIIIA. | Q33240965 | ||
| Transglutaminase regulation of cell function. | Q33707936 | ||
| Tissue transglutaminase: an enzyme with a split personality | Q33730501 | ||
| Protein crosslinking in assembly and remodelling of extracellular matrices: the role of transglutaminases | Q33926887 | ||
| On the Solubility of Fibrin Clots | Q34685095 | ||
| The involvement of blood coagulation factor XIII in fibrinolysis and thrombosis | Q34803276 | ||
| Transglutaminases: crosslinking enzymes with pleiotropic functions | Q35058528 | ||
| Evaluating factor XIII specificity for glutamine-containing substrates using a matrix-assisted laser desorption/ionization time-of-flight mass spectrometry assay. | Q35153828 | ||
| Transglutaminase 2: a molecular Swiss army knife | Q35693361 | ||
| Ca2+-related regulatory function of fibrinogen | Q35989804 | ||
| Transglutaminases as targets for pharmacological inhibition | Q36074670 | ||
| Facilities for macromolecular crystallography at the Helmholtz-Zentrum Berlin | Q36129907 | ||
| Factor XIII and the clotting of fibrinogen: from basic research to medicine | Q36174621 | ||
| Factor XIII: a coagulation factor with multiple plasmatic and cellular functions | Q37899674 | ||
| Transglutaminase as a therapeutic target for celiac disease | Q38269678 | ||
| Phosphorylation of histones by tissue transglutaminase. | Q40331106 | ||
| Coagulation factor XIIIa substrates in human plasma: identification and incorporation into the clot | Q41825512 | ||
| Differences in the inhibition of coagulation factor XIII-A from animal species revealed by Michael Acceptor- and thioimidazol based blockers. | Q44033292 | ||
| Transglutaminase inhibition ameliorates experimental diabetic nephropathy. | Q45953885 | ||
| Expression of transglutaminase 1 in human epidermis | Q71669809 | ||
| Expression of transglutaminase 5 in normal and pathologic human epidermis | Q74786041 | ||
| P577 | publication date | 2020-03-17 | |
| P1433 | published in | ChemMedChem | Q2962252 |
| P1476 | title | Structure-Based Design of FXIIIa-Blockers: Addressing a Transient Hydrophobic Pocket in the Active Site of FXIIIa |
Search more.